Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2022

Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France

Résumé

Meeting Abstract PM2-027
Fichier non déposé

Dates et versions

hal-03714451 , version 1 (05-07-2022)

Identifiants

  • HAL Id : hal-03714451 , version 1

Citer

C. Fougerou-Leurent, C. Delmas, J. Saillard, M. Dumousseaux, A. Ferrane, et al.. Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France. Fundamental & Clinical Pharmacology, 2022, 36, pp.85-85. ⟨hal-03714451⟩
9 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More